JPRN-UMIN000004208已完成未知
The exploratory study of F-18 FAZA PET/CT for patients with non-small cell lung cancer - FAZA PET/CT tests for patients with lung cancer
ational Cancer Center0 个研究点目标入组 30 人开始时间: 2010年9月15日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 30
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- ot applicable 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1) The case who is difficult to be included in the study due to psychological disorder and so on. 2) The case to whom the test agent cannot be injected due to iodine allergy and so on. 3) The case who is judged by the physician in charge not to be included in the study.
研究者
相似试验
已完成
1 期
Exploratory Study of Usefulness of 18F-BPA PET/CT in Clinical Staging of Malignanciespatients with malignanciesJPRN-UMIN000008359"Hotta Group" of National Cancer Center Cancer Research and Development Fund120
已完成
Unknown
A retrospective study using 18F-FDG-PET/CT for the prediction of immunotherapy-related interstitial lung disease in lung cancer.Advanced or recurrent lung cancerJPRN-UMIN000053550iigata University Medical and Dental Hospital165
撤回
2 期
18F-CP18 Imaging Studies for Cancer Treatment With BirinapantOvarian NeoplasmsFallopian Tube NeoplasmsFallopian Tube CancerOvarian CancerNCT01766622National Institutes of Health Clinical Center (CC)
已完成
3 期
A Prospective Study on 18F-DCFPyL PET/CT Imaging in Biochemical Recurrence of Prostate CancerBiochemical recurrent prostate cancer10014713prostate cancerNL-OMON55231Curium PET France30
进行中（未招募）
1 期
A Study on PET/CT Imaging (scan) with 18F-DCFPyL (radioactive substance) of Prostate Cancer having recurred shown by increase in PSA blood levelPatients with histopathologically confirmed prostate adenocarcinoma per original diagnosis and subsequent definitive therapy, with first biochemical recurrenceMedDRA version: 21.0Level: PTClassification code 10036911Term: Prostate cancer recurrentSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)EUCTR2020-000121-37-FRCYCLOPHARMA217